StockVS

American Well Corporation (AMWL) 주식 분석

의료

American Well Corporation

$8.48

+$0.52 (+6.53%)

최종 업데이트: 2026년 5월 26일

가격 추이

분석

회사 개요

American Well Corporation is an enterprise platform and software company that delivers digitally enabling hybrid care solutions across the United States and international markets. The corporation operates within the Healthcare sector, specifically the Health Information Services industry, which focuses on providing the digital infrastructure necessary for scalable healthcare experiences across various care settings. The company employs 562 individuals and maintains a market capitalization of $89.71M with annual revenue of $249.32M. These valuation and revenue figures indicate that the company holds a relatively small position within the broader healthcare technology landscape, reflecting its status as a mid-cap enterprise focused on niche digital enablement rather than broad consumer reach.

재무 건전성

The company reported a revenue of $249.32M over the trailing twelve months, yet recorded a net income of -$95,700,000 and an EBITDA of -$60,111,000. The substantial gap between positive revenue and significant net losses reveals a cost structure where operating expenses, likely driven by research and development or sales costs, significantly outpace gross profitability before interest and taxes. Free cash flow stands at -$12,869,375, indicating that the company is currently consuming cash reserves to fund operations and capital expenditures, which limits immediate financial flexibility for aggressive expansion or acquisitions. Despite the losses, the balance sheet holds $182.33M in cash against only $4.52M in debt, suggesting a heavily cash-rich position relative to its obligations. The debt-to-equity ratio of 1.83 indicates a leveraged balance sheet, yet the high cash balance mitigates immediate solvency risks associated with this leverage. A current ratio of 3.37 demonstrates strong short-term liquidity, implying the company can easily cover its current liabilities with its current assets. However, the return on equity is -33.7% and the return on assets is -15.5%, metrics that reveal management is currently generating negative returns on the capital invested and assets held.

밸류에이션 평가

The trailing twelve months P/E ratio is N/A due to negative earnings, while the forward P/E is -2.74, implying that the market is pricing in a continued trajectory of negative earnings in the near term rather than a turnaround. The price-to-book ratio is 0.38, which indicates that the company's market capitalization is trading at a significant discount to its book value, suggesting the market values the firm's assets at less than their accounting value. The price-to-sales ratio is 0.36, and the EV/EBITDA stands at 1.26, suggesting that traditional valuation multiples are being applied with caution due to the lack of profitability. The stock has traded between a 52-week low of $3.71 and a 52-week high of $9.15, providing a range within which the current price fluctuates based on market sentiment regarding its turnaround potential. The beta of 1.39 indicates that the stock's price volatility is significantly higher than the broader market, meaning the asset will likely experience larger price swings during periods of market turbulence compared to low-beta peers.

Growth & Income

The company experienced a revenue growth of -22.1% year-over-year, while earnings growth is N/A due to the absence of recent net income. The contraction in revenue suggests a challenging operating environment or a reduction in the customer base, as earnings are not growing faster than revenue because both metrics are currently negative. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning it reinvests its limited cash flow and reserves back into the business rather than distributing income to shareholders. The overall growth and income profile characterizes American Well Corporation as a high-volatility, non-income generating stock currently facing revenue contraction while maintaining a substantial cash hoard to navigate the period of negative earnings and operational losses.

동종업체 비교

American Well Corporation (AMWL) 은(는) 의료 정보 서비스 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:

기업명 티커 시가총액 PER
American Well Corporation AMWL $141.69M N/A
Veeva Systems Inc. VEEV $25.87B 29.1
BrightSpring Health Services, Inc. BTSG $11.70B 78.3
Tempus AI, Inc. TEM $8.38B N/A

의료 정보 서비스 산업 평균 PER은 57.5배입니다. American Well Corporation의 PER은 N/A입니다.

이 분석은 AI가 생성한 것으로 정보 제공 목적으로만 사용되며 투자 조언이 아닙니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 직접 조사하고 자격을 갖춘 재무 상담사와 상담하세요.

American Well Corporation 소개

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

회사 설명은 영어로 표시됩니다.

웹사이트 방문 →

주요 지표

시가총액
$141.69M
PER
N/A
52주 최고가
$9.15
52주 최저가
$3.71
평균 거래량
61.08K
베타
1.53

데이터는 yfinance를 통해 Yahoo Finance에서 제공됩니다. 매일 업데이트.

기업 정보

거래소
NYSE
국가
United States
직원 수
562